Photo Release -- Intersect ENT Announces Positive Data From Clinical Trial of New In-Office Implant for Recurrent Chronic Sinusitis
September 22, 2014 08:25 ET
|
Intersect ENT
MENLO PARK, Calif. and Orlando, Fla., Sept. 22, 2014 (GLOBE NEWSWIRE) -- Intersect ENT, Inc. (Nasdaq:XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat...
Intersect ENT Enrolls First Patient in Clinical Study to Expand Access to PROPEL Treatment to Broader Patient Population
September 17, 2014 17:58 ET
|
Intersect ENT
MENLO PARK, Calif., Sept. 17, 2014 (GLOBE NEWSWIRE) -- Intersect ENT, Inc. (Nasdaq:XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, today...
Intersect ENT Reports Second Quarter 2014 Results
September 03, 2014 16:01 ET
|
Intersect ENT
MENLO PARK, Calif., Sept. 3, 2014 (GLOBE NEWSWIRE) -- Intersect ENT, Inc. (Nasdaq:XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, today...
Intersect ENT to Announce Second Quarter Financial Results
August 22, 2014 08:05 ET
|
Intersect ENT
MENLO PARK, Calif., Aug. 22, 2014 (GLOBE NEWSWIRE) -- Intersect ENT, Inc. (Nasdaq:XENT), a company seeking to improve the quality of life for patients with ear, nose and throat conditions, today...
Study Indicates Cost Effectiveness of Intersect ENT's PROPEL Implant for Chronic Sinusitis
August 11, 2014 08:05 ET
|
Intersect ENT
MENLO PARK, Calif., Aug. 11, 2014 (GLOBE NEWSWIRE) -- Intersect ENT, Inc. (Nasdaq:XENT), a company seeking to improve the quality of life for patients with ear, nose and throat conditions, today...
Intersect ENT Announces Closing of its Initial Public Offering
July 29, 2014 16:05 ET
|
Intersect ENT
MENLO PARK, Calif., July 29, 2014 (GLOBE NEWSWIRE) -- Intersect ENT, Inc. (Nasdaq:XENT), a commercial drug-device company committed to improving the quality of life for patients with ear, nose and...
Intersect ENT Announces Pricing of Its Initial Public Offering
July 24, 2014 08:05 ET
|
Intersect ENT
MENLO PARK, Calif., July 24, 2014 (GLOBE NEWSWIRE) -- Intersect ENT, Inc., a commercial drug-device company committed to improving the quality of life for patients with ear, nose and throat...